🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Rhythm Pharmaceuticals, Inc.

RYTM Healthcare
$120.54 +$3.93 (3.37%)
Market Cap: $8.36 B
Gurus Holding
7
Popularity Rank
#1079
% of Shares Held
1.96%
Net Activity (Q3 2026)
+$56.41 M

Guru Ownership Trend

Guru Analysis for Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals, Inc. (RYTM), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $163.87 M.

Top institutional holders include Steven Cohen and Stanley Druckenmiller.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $56.41 M net inflow during the quarter.

Recent activity highlights Ken Fisher who opened a new position. Conversely, Joel Greenblatt reduced exposure by 7.4%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q3 2026)

+$57.99 M
Total Buy Value
New Buys 2
Additions 4
-$1.58 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
2
Net Buyers
6

FAQs for Rhythm Pharmaceuticals, Inc. (RYTM)

Major holders include Steven Cohen ($69.17 M), Stanley Druckenmiller ($25.7 M), Ken Fisher ($10.09 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 1.36 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $56.41 M, with 6 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited RYTM. The total reported sell value was $1.58 M.

Yes, 2 managers opened new positions in RYTM, and 4 increased their existing holdings. The total reported buy value was $57.99 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.08% Add 75.4% 726,499 $69.17 M Q3 2026
0.57% Add 32.6% 269,900 $25.7 M Q3 2026
0.00% New Buy 105,999 $10.09 M Q3 2026
0.04% New Buy 95,074 $9.05 M Q3 2026
0.01% Add 29.9% 88,681 $8.44 M Q3 2026
0.00% Add 15.2% 68,211 $6.49 M Q3 2026
0.00% Reduce -7.4% 5,107 $486,263 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form